Big Opportunity: India's Third Giant Leap
Here is the latest financial fact sheet of ZYDUS LIFESCIENCES. For more details, see the ZYDUS LIFESCIENCES quarterly results and ZYDUS LIFESCIENCES share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.2 |
No. of shares | m | 1,012.20 |
1 Week | % | 1.3 |
1 Month | % | 10.2 |
1 Year | % | 56.1 |
52 week H/L | Rs | 668.5/401.1 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
ZYDUS LIFESCIENCES EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 432 | 352 | 509 | 674 | 495 | |
Low | Rs | 306 | 207 | 259 | 331 | 319 | |
Sales per share (Unadj.) | Rs | 128.6 | 139.2 | 140.7 | 147.6 | 170.3 | |
Earnings per share (Unadj.) | Rs | 18.1 | 11.5 | 21.5 | 22.7 | 19.8 | |
Diluted earnings per share | Rs | 18.3 | 11.6 | 21.8 | 23.0 | 19.8 | |
Cash flow per share (Unadj.) | Rs | 23.9 | 18.3 | 28.1 | 29.7 | 26.9 | |
Dividends per share (Unadj.) | Rs | 3.50 | 3.50 | 3.50 | 2.50 | 6.00 | |
Adj. dividends per share | Rs | 3.54 | 3.54 | 3.54 | 2.53 | 6.00 | |
Avg Dividend yield | % | 0.9 | 1.3 | 0.9 | 0.5 | 1.5 | |
Book value per share (Unadj.) | Rs | 101.5 | 101.4 | 126.9 | 166.1 | 173.0 | |
Adj. book value per share | Rs | 102.6 | 102.5 | 128.4 | 167.9 | 173.0 | |
Shares outstanding (eoy) | m | 1,023.74 | 1,023.74 | 1,023.74 | 1,023.74 | 1,012.20 | |
Price / Sales ratio | x | 2.9 | 2.0 | 2.7 | 3.4 | 2.4 | |
Avg P/E ratio | x | 20.4 | 24.3 | 17.8 | 22.1 | 20.6 | |
P/CF ratio (eoy) | x | 15.4 | 15.3 | 13.7 | 16.9 | 15.1 | |
Price / Book Value ratio | x | 3.6 | 2.8 | 3.0 | 3.0 | 2.4 | |
Dividend payout | % | 19.3 | 30.5 | 16.2 | 11.0 | 30.3 | |
Avg Mkt Cap | Rs m | 378,171 | 286,034 | 393,092 | 514,277 | 412,144 | |
Total wages/salary | Rs m | 19,032 | 21,698 | 20,695 | 21,777 | 24,564 |
ZYDUS LIFESCIENCES INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 131,656 | 142,531 | 144,035 | 151,099 | 172,374 | |
Other income | Rs m | 2,085 | 1,171 | 750 | 3,907 | 4,746 | |
Total revenues | Rs m | 133,741 | 143,702 | 144,785 | 155,006 | 177,120 | |
Gross profit | Rs m | 29,680 | 24,166 | 31,802 | 32,874 | 29,677 | |
Depreciation | Rs m | 5,986 | 6,965 | 6,696 | 7,130 | 7,227 | |
Interest | Rs m | 1,958 | 3,418 | 1,864 | 1,270 | 1,299 | |
Profit before tax | Rs m | 23,821 | 14,954 | 23,992 | 28,381 | 25,897 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 5,303 | 3,198 | 1,936 | 5,117 | 5,878 | |
Profit after tax | Rs m | 18,518 | 11,756 | 22,056 | 23,264 | 20,019 | |
Gross profit margin | % | 22.5 | 17.0 | 22.1 | 21.8 | 17.2 | |
Effective tax rate | % | 22.3 | 21.4 | 8.1 | 18.0 | 22.7 | |
Net profit margin | % | 14.1 | 8.2 | 15.3 | 15.4 | 11.6 |
ZYDUS LIFESCIENCES BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 84,981 | 87,154 | 87,160 | 120,952 | 100,082 | |
Current liabilities | Rs m | 73,425 | 82,694 | 78,613 | 78,268 | 55,267 | |
Net working cap to sales | % | 8.8 | 3.1 | 5.9 | 28.2 | 26.0 | |
Current ratio | x | 1.2 | 1.1 | 1.1 | 1.5 | 1.8 | |
Inventory Days | Days | 34 | 35 | 35 | 94 | 50 | |
Debtors Days | Days | 110 | 94 | 79 | 81 | 94 | |
Net fixed assets | Rs m | 140,147 | 141,183 | 140,943 | 144,382 | 144,776 | |
Share capital | Rs m | 1,024 | 1,024 | 1,024 | 1,024 | 1,012 | |
"Free" reserves | Rs m | 102,839 | 102,733 | 128,899 | 168,972 | 174,146 | |
Net worth | Rs m | 103,863 | 103,757 | 129,923 | 169,996 | 175,158 | |
Long term debt | Rs m | 39,497 | 32,146 | 6,095 | 3,621 | 0 | |
Total assets | Rs m | 225,128 | 228,337 | 228,103 | 266,996 | 244,940 | |
Interest coverage | x | 13.2 | 5.4 | 13.9 | 23.3 | 20.9 | |
Debt to equity ratio | x | 0.4 | 0.3 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | |
Return on assets | % | 9.1 | 6.6 | 10.5 | 9.2 | 8.7 | |
Return on equity | % | 17.8 | 11.3 | 17.0 | 13.7 | 11.4 | |
Return on capital | % | 18.0 | 13.5 | 19.0 | 17.1 | 15.5 | |
Exports to sales | % | 36.8 | 37.0 | 44.1 | 41.7 | 39.2 | |
Imports to sales | % | 8.8 | 10.2 | 11.0 | 14.5 | 11.9 | |
Exports (fob) | Rs m | 48,404 | 52,752 | 63,535 | 63,065 | 67,577 | |
Imports (cif) | Rs m | 11,593 | 14,504 | 15,911 | 21,869 | 20,544 | |
Fx inflow | Rs m | 48,404 | 52,752 | 63,535 | 63,065 | 67,577 | |
Fx outflow | Rs m | 11,593 | 14,504 | 15,911 | 21,869 | 20,544 | |
Net fx | Rs m | 36,811 | 38,248 | 47,624 | 41,196 | 47,033 |
ZYDUS LIFESCIENCES CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 12,819 | 29,315 | 32,939 | 21,045 | 26,888 | |
From Investments | Rs m | -42,387 | -10,123 | -7,246 | -10,003 | 11,712 | |
From Financial Activity | Rs m | 18,846 | -15,282 | -25,477 | -8,683 | -44,004 | |
Net Cashflow | Rs m | -8,109 | 3,989 | -905 | 2,186 | -5,338 |
Share Holding
Shareholding as on Sep 2023
|
Company Information
|
CHM: Pankaj R Patel | COMP SEC: Dhaval N Soni | YEAR OF INC: 1995 | BSE CODE: 532321 | FV (Rs): 1 | DIV YIELD (%): 0.9 |
Read: ZYDUS LIFESCIENCES 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: AUROBINDO PHARMA DR. REDDYS LAB PIRAMAL ENTERPRISES CIPLA LUPIN
Compare ZYDUS LIFESCIENCES With: AUROBINDO PHARMA DR. REDDYS LAB PIRAMAL ENTERPRISES CIPLA LUPIN
After opening the day on a positive note, Indian share markets continued the momentum as the session progressed and ended the day higher.